DE3523615A1 - Medizinisches geraet, insbesondere kanuele, katheter oder implantat - Google Patents
Medizinisches geraet, insbesondere kanuele, katheter oder implantatInfo
- Publication number
- DE3523615A1 DE3523615A1 DE19853523615 DE3523615A DE3523615A1 DE 3523615 A1 DE3523615 A1 DE 3523615A1 DE 19853523615 DE19853523615 DE 19853523615 DE 3523615 A DE3523615 A DE 3523615A DE 3523615 A1 DE3523615 A1 DE 3523615A1
- Authority
- DE
- Germany
- Prior art keywords
- plastic
- medical device
- plastic surface
- gamma globulins
- gamma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007943 implant Substances 0.000 title claims description 9
- 239000004033 plastic Substances 0.000 claims abstract description 30
- 229920003023 plastic Polymers 0.000 claims abstract description 30
- 108010074605 gamma-Globulins Proteins 0.000 claims abstract description 17
- 239000002184 metal Substances 0.000 claims abstract description 3
- 229910052751 metal Inorganic materials 0.000 claims abstract description 3
- 239000002318 adhesion promoter Substances 0.000 claims description 5
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical group ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 4
- -1 polypropylene Polymers 0.000 claims description 3
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 238000005530 etching Methods 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920000193 polymethacrylate Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920002635 polyurethane Polymers 0.000 claims description 2
- 239000004814 polyurethane Substances 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 238000000992 sputter etching Methods 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims 2
- 239000004642 Polyimide Substances 0.000 claims 1
- 239000004721 Polyphenylene oxide Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000007822 coupling agent Substances 0.000 claims 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 claims 1
- 235000013312 flour Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229920002492 poly(sulfone) Polymers 0.000 claims 1
- 229920000728 polyester Polymers 0.000 claims 1
- 229920000570 polyether Polymers 0.000 claims 1
- 229920001721 polyimide Polymers 0.000 claims 1
- 229920000098 polyolefin Polymers 0.000 claims 1
- 229920000915 polyvinyl chloride Polymers 0.000 claims 1
- 239000004800 polyvinyl chloride Substances 0.000 claims 1
- 229920002379 silicone rubber Polymers 0.000 claims 1
- 239000004945 silicone rubber Substances 0.000 claims 1
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 claims 1
- 241001631457 Cannula Species 0.000 description 7
- 244000052616 bacterial pathogen Species 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000004744 fabric Substances 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 238000007788 roughening Methods 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 150000002497 iodine compounds Chemical class 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853523615 DE3523615A1 (de) | 1985-07-02 | 1985-07-02 | Medizinisches geraet, insbesondere kanuele, katheter oder implantat |
| EP86108875A EP0214392B1 (de) | 1985-07-02 | 1986-06-30 | Medizinisches Gerät, insbesondere Filter, Kanüle, Katheter oder Implantat |
| AT86108875T ATE52924T1 (de) | 1985-07-02 | 1986-06-30 | Medizinisches geraet, insbesondere filter, kanuele, katheter oder implantat. |
| DE8686108875T DE3671376D1 (de) | 1985-07-02 | 1986-06-30 | Medizinisches geraet, insbesondere filter, kanuele, katheter oder implantat. |
| JP61155902A JPS6226066A (ja) | 1985-07-02 | 1986-07-02 | 医療用器具、特にフイルタ、カニユ−レ、カテ−テルまたはインプラント |
| US07/420,700 US5061237A (en) | 1985-07-02 | 1989-10-11 | Method of purifying whole blood |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853523615 DE3523615A1 (de) | 1985-07-02 | 1985-07-02 | Medizinisches geraet, insbesondere kanuele, katheter oder implantat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3523615A1 true DE3523615A1 (de) | 1987-01-15 |
| DE3523615C2 DE3523615C2 (enExample) | 1988-02-04 |
Family
ID=6274747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19853523615 Granted DE3523615A1 (de) | 1985-07-02 | 1985-07-02 | Medizinisches geraet, insbesondere kanuele, katheter oder implantat |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS6226066A (enExample) |
| DE (1) | DE3523615A1 (enExample) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989005762A1 (en) * | 1987-12-18 | 1989-06-29 | Tiedemanns Johan H. Andresen | Control of biological characteristics of material |
| WO1989008471A1 (en) * | 1988-03-07 | 1989-09-21 | Leocor, Inc. | Low-profile angioplasty balloon catheter with guidewire |
| EP0351687A3 (en) * | 1988-07-18 | 1990-07-11 | Advanced Cardiovascular Systems, Inc. | Vascular catheter |
| WO1992013018A1 (en) * | 1991-01-25 | 1992-08-06 | Kodak Limited | Polymers and products derived therefrom |
| EP0447143A3 (en) * | 1990-03-12 | 1993-03-31 | E.I. Du Pont De Nemours And Company | Carrier for biochemically active substances |
| WO2007008408A3 (en) * | 2005-07-08 | 2007-04-05 | Advanced Cardiovascular System | Functionalized chemically inert polymers for coatings |
| DE10053554B4 (de) * | 2000-10-28 | 2007-07-05 | Fresenius Medical Care Deutschland Gmbh | Beschichtungsverfahren zur Erhöhung der Wärmestandfestigkeit und Hydrophilierung der Oberflächen von Substraten und damit erhaltene Werkstücke |
| US20110293598A1 (en) * | 2010-05-26 | 2011-12-01 | Baxter Healthcare S.A. | Method to produce an immunoglobulin preparation with improved yield |
| US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| US8940877B2 (en) | 2010-05-26 | 2015-01-27 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
| WO2021061156A1 (en) * | 2019-09-27 | 2021-04-01 | Bard Peripheral Vascular, Inc. | Medical devices coated with antibodies for determining bacterial infections in blood |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2725573T3 (es) * | 2012-05-14 | 2019-09-24 | Childrens Medical Center | Sistema para la modificación extracorpórea de sangre |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0061312A1 (en) * | 1981-03-19 | 1982-09-29 | Board Of Regents, The University Of Texas System | Alkyl-substituted polymers having enhanced albumin affinity |
| FR2554349A1 (fr) * | 1983-11-08 | 1985-05-10 | Immunotech Sa | Procede d'obtention de materiaux biocompatibles, materiaux obtenus par ce procede et leurs applications |
-
1985
- 1985-07-02 DE DE19853523615 patent/DE3523615A1/de active Granted
-
1986
- 1986-07-02 JP JP61155902A patent/JPS6226066A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0061312A1 (en) * | 1981-03-19 | 1982-09-29 | Board Of Regents, The University Of Texas System | Alkyl-substituted polymers having enhanced albumin affinity |
| FR2554349A1 (fr) * | 1983-11-08 | 1985-05-10 | Immunotech Sa | Procede d'obtention de materiaux biocompatibles, materiaux obtenus par ce procede et leurs applications |
Non-Patent Citations (1)
| Title |
|---|
| Derwent Referat 27211 E/14 betreffend die JP-PA 10 84 68 vom 07.08.80 * |
Cited By (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU645242B2 (en) * | 1987-12-18 | 1994-01-13 | Repligen Corporation | Packaging for liquids having anti-microbial agents adhered thereto |
| WO1989005762A1 (en) * | 1987-12-18 | 1989-06-29 | Tiedemanns Johan H. Andresen | Control of biological characteristics of material |
| WO1989008471A1 (en) * | 1988-03-07 | 1989-09-21 | Leocor, Inc. | Low-profile angioplasty balloon catheter with guidewire |
| EP0351687A3 (en) * | 1988-07-18 | 1990-07-11 | Advanced Cardiovascular Systems, Inc. | Vascular catheter |
| EP0447143A3 (en) * | 1990-03-12 | 1993-03-31 | E.I. Du Pont De Nemours And Company | Carrier for biochemically active substances |
| US5356374A (en) * | 1990-03-12 | 1994-10-18 | E. I. Du Pont De Nemours And Company | Process for treating blood with polyimide carriers |
| WO1992013018A1 (en) * | 1991-01-25 | 1992-08-06 | Kodak Limited | Polymers and products derived therefrom |
| DE10053554B4 (de) * | 2000-10-28 | 2007-07-05 | Fresenius Medical Care Deutschland Gmbh | Beschichtungsverfahren zur Erhöhung der Wärmestandfestigkeit und Hydrophilierung der Oberflächen von Substraten und damit erhaltene Werkstücke |
| US8367093B2 (en) | 2005-07-08 | 2013-02-05 | Advanced Cardiovascular Systems, Inc. | Functionalized chemically inert polymers for coatings |
| WO2007008408A3 (en) * | 2005-07-08 | 2007-04-05 | Advanced Cardiovascular System | Functionalized chemically inert polymers for coatings |
| US8263107B2 (en) | 2005-07-08 | 2012-09-11 | Advanced Cardiovascular Systems, Inc. | Functionalized chemically inert polymers for coatings |
| US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| US9468675B2 (en) | 2010-05-26 | 2016-10-18 | Baxalta Incorporated | Removal of serine proteases by treatment with finely divided silicon dioxide |
| US8796430B2 (en) * | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
| US8889838B2 (en) | 2010-05-26 | 2014-11-18 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| US8921520B2 (en) | 2010-05-26 | 2014-12-30 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| US8940877B2 (en) | 2010-05-26 | 2015-01-27 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
| US8993734B2 (en) | 2010-05-26 | 2015-03-31 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
| US20110293598A1 (en) * | 2010-05-26 | 2011-12-01 | Baxter Healthcare S.A. | Method to produce an immunoglobulin preparation with improved yield |
| US9708391B2 (en) | 2010-05-26 | 2017-07-18 | Baxalta Incorporated | Removal of serine proteases by treatment with finely divided silicon dioxide |
| US10208106B2 (en) | 2010-05-26 | 2019-02-19 | Baxalta Incorporated | Removal of serine proteases by treatment with finely divided silicon dioxide |
| US10875906B2 (en) | 2010-05-26 | 2020-12-29 | Baxalta Incorporated | Removal of serine proteases by treatment with finely divided silicon dioxide |
| US11891431B2 (en) | 2010-05-26 | 2024-02-06 | Takeda Pharm Limited ceutical Company Limited | Removal of serine proteases by treatment with finely divided silicon dioxide |
| US11617544B2 (en) | 2019-09-27 | 2023-04-04 | Bard Peripheral Vascular, Inc. | Medical devices and methods thereof for determining bacterial infections in blood |
| WO2021061156A1 (en) * | 2019-09-27 | 2021-04-01 | Bard Peripheral Vascular, Inc. | Medical devices coated with antibodies for determining bacterial infections in blood |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3523615C2 (enExample) | 1988-02-04 |
| JPS6226066A (ja) | 1987-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3523615A1 (de) | Medizinisches geraet, insbesondere kanuele, katheter oder implantat | |
| DE69725205T2 (de) | Befestigung von Biomolekülen | |
| DE69527899T2 (de) | Herstellungsmethode für einen intraluminalen Stent | |
| DE69527900T2 (de) | Eine Arznei eluierendes Stent | |
| DE69822872T2 (de) | Verfahren zur oxidativen bindung von glycoproteinen und glycopeptiden an oberflächen von medizinischen artikeln | |
| JP2828433B2 (ja) | 強化された感染抵抗を有する筋肉内刺激リード | |
| DE69905258T2 (de) | Verwendung einer zusammensetzung mit heparin als nicht-thrombogenes oberflächenbeschichtungsmittel zur prophylaxe von arterienthrobosen | |
| DE68920671T2 (de) | Ein mit Hirudin, deren Analoge oder deren Fragmente beschichtetes bioverträgliches und thromboresistentes Material und seine Herstellung. | |
| DE69131486T2 (de) | Katheter als arzneiabgabesystem | |
| DE69330271T2 (de) | Antibakteriell beschichtete, medizinische implantate | |
| DE69628585T2 (de) | Verfahren zur herstellung von heparinisierten biomaterialien | |
| US5061237A (en) | Method of purifying whole blood | |
| DE69801459T2 (de) | Beschichteter endovaskulärer Stent | |
| DE3725728C2 (enExample) | ||
| DE19533682A1 (de) | Verfahren zum Anlagern und Immobilisieren von Heparin auf anorganischen Substratoberflächen von kardiovaskulären Implantanten | |
| DE10004884A1 (de) | Verfahren zum Anbringen von Biomolekülen an Oberflächen mittels funktioneller Amin-Gruppen | |
| Keogh et al. | Albumin binding surfaces for biomaterials | |
| DE3247517A1 (de) | Auslassvorrichtung fuer einen urin-sammelbehaelter und verfahren zum verhindern oder verringern des durchgangs von bakterien hierdurch | |
| DE2326863A1 (de) | Verfahren zur herstellung biokompatibler und biofunktioneller materialien | |
| DE1930136B2 (de) | Beschichteter Katheter, sowie Verfahren zu seiner Herstellung | |
| EP2272545B1 (en) | Antimicrobial medical devices and methods of preparation thereof | |
| DE69231691T2 (de) | Verfahren zum schützen von prothesen und provisorisch oder permanent implantierbare materialien gegen bakterielle kolonisation und infektion | |
| US6231495B1 (en) | Radiation emitting, elastic hose for the endovascular therapy | |
| EP0214392B1 (de) | Medizinisches Gerät, insbesondere Filter, Kanüle, Katheter oder Implantat | |
| DE2732437B2 (de) | Wasserunlösliches Haptoglobinpräparat und Verfahren zu seiner Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |